Oridis Biomed

Oridis Biomed was a biotechnology company based in Graz, Austria, that specialized in biobanking and the identification of novel drug targets and biomarkers, particularly in the field of liver diseases and oncology. A spin-off from the Medical University of Graz, the company utilized a proprietary platform that integrated high-quality clinical tissue samples with comprehensive pathological and clinical data. Their business model focused on providing pharmaceutical and diagnostic companies with validated targets and molecular profiles to accelerate drug development. In 2008, the company was acquired by Aureus Pharma to bolster its knowledge management and drug discovery database offerings. The integration of Oridis's clinical data into Aureus's knowledge systems provided a unique resource for researchers in the hepatology space.